| 47.7 |
143.0 |
GO:0060466 |
activation of meiosis involved in egg activation(GO:0060466) |
| 41.0 |
123.1 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 40.0 |
120.0 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 30.5 |
91.5 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 29.1 |
87.4 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 26.0 |
51.9 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 24.5 |
98.2 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 23.9 |
71.8 |
GO:0046959 |
habituation(GO:0046959) |
| 23.6 |
330.1 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 23.5 |
94.2 |
GO:0097477 |
lateral motor column neuron migration(GO:0097477) |
| 20.0 |
59.9 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 18.7 |
56.1 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 17.8 |
53.5 |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 17.5 |
52.6 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 16.1 |
80.3 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 15.9 |
63.4 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
| 15.4 |
15.4 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 15.2 |
76.1 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 14.9 |
238.6 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 14.7 |
88.0 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 14.6 |
58.6 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 14.5 |
58.1 |
GO:0021586 |
pons maturation(GO:0021586) |
| 14.5 |
58.1 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 14.2 |
226.6 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 13.7 |
54.8 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 13.4 |
40.2 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 12.9 |
12.9 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 12.9 |
25.8 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 12.8 |
51.1 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 12.7 |
38.1 |
GO:0003195 |
tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
| 12.2 |
85.3 |
GO:0032811 |
negative regulation of epinephrine secretion(GO:0032811) |
| 12.0 |
60.2 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 11.7 |
35.1 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 11.6 |
46.2 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 11.5 |
57.6 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 11.1 |
33.2 |
GO:1901254 |
positive regulation of intracellular transport of viral material(GO:1901254) |
| 10.7 |
181.7 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 10.6 |
53.1 |
GO:0002182 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 10.6 |
10.6 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 10.6 |
63.3 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 10.5 |
84.1 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 10.2 |
41.0 |
GO:0031622 |
positive regulation of fever generation(GO:0031622) |
| 10.2 |
235.5 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 10.2 |
30.5 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 10.0 |
40.1 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 9.8 |
29.3 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 9.7 |
9.7 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 9.6 |
28.9 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 9.6 |
38.5 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 9.6 |
28.8 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 9.6 |
9.6 |
GO:1904861 |
excitatory synapse assembly(GO:1904861) |
| 9.5 |
38.0 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 9.5 |
94.8 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 9.4 |
28.2 |
GO:0060023 |
soft palate development(GO:0060023) |
| 9.3 |
46.4 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 9.2 |
46.2 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 9.2 |
27.6 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 9.0 |
18.0 |
GO:1900453 |
negative regulation of long term synaptic depression(GO:1900453) |
| 8.9 |
26.8 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 8.9 |
124.4 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 8.9 |
17.7 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 8.8 |
26.4 |
GO:0021649 |
vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve structural organization(GO:0021649) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) dorsal root ganglion development(GO:1990791) |
| 8.7 |
43.5 |
GO:0021960 |
anterior commissure morphogenesis(GO:0021960) |
| 8.6 |
34.4 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 8.5 |
25.5 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 8.4 |
16.9 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 8.4 |
101.1 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 8.4 |
16.8 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 8.3 |
74.3 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 8.1 |
24.4 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 8.1 |
8.1 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 8.0 |
8.0 |
GO:2000830 |
vacuolar phosphate transport(GO:0007037) vitamin D3 metabolic process(GO:0070640) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 8.0 |
32.1 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 7.9 |
23.7 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 7.8 |
23.4 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 7.8 |
7.8 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 7.7 |
46.3 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 7.7 |
7.7 |
GO:0014053 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
| 7.7 |
38.4 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 7.7 |
107.4 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 7.6 |
61.2 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 7.6 |
38.1 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 7.5 |
22.4 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 7.5 |
37.3 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 7.4 |
36.9 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 7.3 |
7.3 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 7.3 |
21.9 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 7.3 |
21.9 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 7.3 |
36.3 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 7.2 |
7.2 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 7.2 |
28.9 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 7.2 |
14.4 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 7.2 |
71.6 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 7.2 |
28.6 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 6.9 |
68.5 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 6.8 |
6.8 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 6.8 |
20.4 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 6.8 |
20.3 |
GO:0090327 |
negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 6.7 |
33.7 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 6.7 |
33.4 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 6.7 |
40.0 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 6.6 |
45.9 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 6.5 |
45.7 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 6.5 |
71.8 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 6.5 |
6.5 |
GO:0018307 |
enzyme active site formation(GO:0018307) |
| 6.5 |
19.4 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 6.4 |
32.1 |
GO:0034183 |
negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 6.4 |
25.6 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 6.4 |
51.1 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 6.3 |
6.3 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 6.3 |
156.9 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 6.3 |
18.8 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 6.3 |
75.0 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 6.2 |
18.7 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 6.2 |
6.2 |
GO:0033605 |
positive regulation of catecholamine secretion(GO:0033605) |
| 6.2 |
24.9 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 6.2 |
43.1 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 6.1 |
12.3 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 6.1 |
12.2 |
GO:0003025 |
regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 6.0 |
48.4 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 6.0 |
18.1 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 6.0 |
48.2 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 6.0 |
78.4 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 6.0 |
18.1 |
GO:0048208 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 6.0 |
35.8 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 5.9 |
65.1 |
GO:0014041 |
regulation of neuron maturation(GO:0014041) |
| 5.9 |
70.6 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 5.9 |
35.2 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 5.8 |
17.5 |
GO:2000598 |
regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
| 5.8 |
5.8 |
GO:0051956 |
negative regulation of amino acid transport(GO:0051956) |
| 5.8 |
17.4 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 5.8 |
11.6 |
GO:0098908 |
regulation of neuronal action potential(GO:0098908) positive regulation of neuronal action potential(GO:1904457) |
| 5.8 |
23.1 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
| 5.7 |
17.1 |
GO:0018377 |
N-terminal protein myristoylation(GO:0006499) N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) protein myristoylation(GO:0018377) |
| 5.7 |
17.1 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 5.7 |
11.3 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 5.6 |
16.9 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) |
| 5.6 |
50.3 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 5.5 |
33.1 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 5.5 |
109.8 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 5.5 |
21.9 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 5.5 |
21.9 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 5.4 |
43.6 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 5.4 |
54.3 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 5.4 |
10.9 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 5.4 |
37.6 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 5.4 |
21.5 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 5.3 |
42.5 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 5.3 |
10.5 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
| 5.3 |
36.8 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 5.2 |
52.3 |
GO:0044090 |
positive regulation of vacuole organization(GO:0044090) |
| 5.2 |
26.0 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 5.1 |
5.1 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 5.0 |
15.1 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 5.0 |
15.0 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 5.0 |
14.9 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 5.0 |
143.7 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 4.9 |
29.6 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 4.9 |
19.7 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 4.9 |
29.5 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 4.9 |
24.5 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 4.9 |
92.7 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 4.9 |
4.9 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 4.9 |
14.6 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 4.8 |
24.1 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 4.8 |
14.5 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 4.8 |
57.7 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 4.8 |
28.8 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 4.8 |
28.5 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 4.7 |
42.7 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 4.7 |
33.1 |
GO:0097324 |
melanocyte migration(GO:0097324) |
| 4.7 |
28.4 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 4.7 |
18.8 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 4.7 |
28.2 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 4.7 |
14.1 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 4.7 |
18.7 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 4.7 |
28.0 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 4.6 |
9.3 |
GO:0021764 |
amygdala development(GO:0021764) |
| 4.6 |
23.2 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 4.6 |
23.1 |
GO:0031000 |
response to caffeine(GO:0031000) |
| 4.6 |
32.2 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 4.6 |
13.7 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 4.5 |
40.8 |
GO:0031280 |
negative regulation of cyclase activity(GO:0031280) |
| 4.5 |
45.3 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 4.5 |
36.2 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 4.5 |
67.8 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 4.5 |
13.5 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 4.5 |
330.8 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 4.5 |
58.0 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 4.4 |
8.9 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 4.4 |
8.9 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 4.4 |
13.3 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 4.4 |
4.4 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 4.4 |
13.2 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 4.4 |
4.4 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 4.4 |
34.9 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 4.3 |
21.7 |
GO:0030242 |
pexophagy(GO:0030242) |
| 4.3 |
13.0 |
GO:1903207 |
neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 4.3 |
8.7 |
GO:0031394 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 4.3 |
17.2 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 4.3 |
17.2 |
GO:0035743 |
CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 4.2 |
12.7 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
| 4.2 |
42.1 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 4.2 |
24.9 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 4.2 |
12.5 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 4.2 |
12.5 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 4.1 |
4.1 |
GO:0010523 |
negative regulation of calcium ion transport into cytosol(GO:0010523) |
| 4.1 |
20.7 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 4.1 |
8.2 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 4.1 |
110.6 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 4.1 |
8.2 |
GO:0033003 |
regulation of mast cell activation(GO:0033003) |
| 4.1 |
8.2 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 4.0 |
72.8 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 4.0 |
12.1 |
GO:0034088 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 4.0 |
16.1 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 4.0 |
16.0 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 4.0 |
8.0 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 4.0 |
4.0 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 4.0 |
4.0 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 4.0 |
7.9 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 4.0 |
11.9 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 3.9 |
7.9 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 3.9 |
15.7 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 3.9 |
19.5 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 3.9 |
27.4 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 3.9 |
19.5 |
GO:0060012 |
synaptic transmission, glycinergic(GO:0060012) |
| 3.9 |
11.7 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 3.9 |
46.6 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 3.9 |
57.9 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 3.9 |
11.6 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 3.8 |
23.1 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 3.8 |
45.9 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 3.8 |
19.1 |
GO:1901660 |
calcium ion export(GO:1901660) |
| 3.8 |
11.4 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 3.8 |
19.0 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 3.8 |
3.8 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 3.8 |
15.0 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 3.8 |
26.3 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 3.7 |
3.7 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 3.7 |
7.3 |
GO:0070162 |
adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 3.7 |
29.3 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
| 3.7 |
14.6 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 3.7 |
3.7 |
GO:0035984 |
response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 3.7 |
18.3 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 3.6 |
14.6 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) |
| 3.6 |
3.6 |
GO:0003383 |
apical constriction(GO:0003383) |
| 3.6 |
18.0 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 3.6 |
14.3 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 3.5 |
17.7 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 3.5 |
14.2 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 3.5 |
10.6 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 3.5 |
24.7 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 3.5 |
7.1 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 3.5 |
7.0 |
GO:0043369 |
CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
| 3.5 |
10.5 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 3.5 |
3.5 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 3.5 |
17.5 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 3.5 |
76.8 |
GO:1900449 |
regulation of glutamate receptor signaling pathway(GO:1900449) |
| 3.5 |
3.5 |
GO:1903061 |
regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 3.4 |
3.4 |
GO:0072319 |
vesicle uncoating(GO:0072319) |
| 3.4 |
13.7 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 3.4 |
23.9 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 3.4 |
85.2 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 3.4 |
13.6 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 3.4 |
16.9 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 3.4 |
13.5 |
GO:0032429 |
regulation of phospholipase A2 activity(GO:0032429) |
| 3.4 |
6.7 |
GO:0070346 |
positive regulation of fat cell proliferation(GO:0070346) |
| 3.4 |
10.1 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 3.4 |
6.7 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 3.3 |
13.4 |
GO:0002327 |
immature B cell differentiation(GO:0002327) |
| 3.3 |
238.6 |
GO:0099643 |
neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
| 3.3 |
33.1 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 3.3 |
19.8 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 3.3 |
3.3 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 3.3 |
46.2 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 3.3 |
13.1 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 3.3 |
6.6 |
GO:0090218 |
positive regulation of lipid kinase activity(GO:0090218) |
| 3.3 |
3.3 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 3.3 |
6.5 |
GO:0044860 |
protein localization to plasma membrane raft(GO:0044860) |
| 3.3 |
9.8 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 3.3 |
9.8 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 3.3 |
3.3 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 3.2 |
16.1 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 3.2 |
3.2 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 3.2 |
9.6 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 3.2 |
92.8 |
GO:0042220 |
response to cocaine(GO:0042220) |
| 3.2 |
15.9 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 3.2 |
6.3 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 3.1 |
9.4 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 3.1 |
15.7 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 3.1 |
6.3 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 3.1 |
21.9 |
GO:0071435 |
potassium ion export(GO:0071435) |
| 3.1 |
18.7 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 3.1 |
6.2 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 3.1 |
3.1 |
GO:0042045 |
epithelial fluid transport(GO:0042045) |
| 3.1 |
3.1 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 3.1 |
3.1 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 3.1 |
12.4 |
GO:0032225 |
regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 3.1 |
3.1 |
GO:0090494 |
catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 3.1 |
6.1 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 3.1 |
110.1 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 3.1 |
12.2 |
GO:0018197 |
peptidyl-aspartic acid modification(GO:0018197) |
| 3.0 |
3.0 |
GO:0009620 |
response to fungus(GO:0009620) |
| 3.0 |
3.0 |
GO:0031645 |
negative regulation of neurological system process(GO:0031645) |
| 3.0 |
9.0 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 3.0 |
9.0 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 3.0 |
17.9 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 3.0 |
26.9 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 3.0 |
3.0 |
GO:0072008 |
glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
| 3.0 |
8.9 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 3.0 |
8.9 |
GO:0036216 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 3.0 |
20.7 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 3.0 |
5.9 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 2.9 |
26.5 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 2.9 |
5.8 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 2.9 |
17.3 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 2.9 |
5.7 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 2.9 |
17.2 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 2.9 |
51.5 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 2.9 |
5.7 |
GO:0015844 |
monoamine transport(GO:0015844) |
| 2.9 |
2.9 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 2.8 |
14.2 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 2.8 |
11.3 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 2.8 |
5.6 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 2.8 |
25.3 |
GO:0007379 |
segment specification(GO:0007379) |
| 2.8 |
8.4 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 2.8 |
28.0 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 2.8 |
69.7 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 2.8 |
13.9 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 2.8 |
13.9 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 2.8 |
5.5 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 2.8 |
2.8 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 2.8 |
8.3 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 2.7 |
22.0 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 2.7 |
8.2 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 2.7 |
8.2 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 2.7 |
5.5 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 2.7 |
2.7 |
GO:1900452 |
regulation of long term synaptic depression(GO:1900452) |
| 2.7 |
5.5 |
GO:2001258 |
negative regulation of cation channel activity(GO:2001258) |
| 2.7 |
5.4 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 2.7 |
24.4 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 2.7 |
8.1 |
GO:0070649 |
formin-nucleated actin cable assembly(GO:0070649) |
| 2.7 |
10.8 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 2.7 |
5.4 |
GO:0072053 |
renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 2.7 |
8.0 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 2.7 |
24.1 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 2.7 |
24.1 |
GO:0046337 |
phosphatidylethanolamine metabolic process(GO:0046337) |
| 2.7 |
8.0 |
GO:0031038 |
myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 2.7 |
2.7 |
GO:0043585 |
nose morphogenesis(GO:0043585) |
| 2.6 |
13.2 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 2.6 |
21.0 |
GO:0048520 |
positive regulation of behavior(GO:0048520) |
| 2.6 |
86.6 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 2.6 |
18.4 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 2.6 |
7.9 |
GO:1902605 |
heterotrimeric G-protein complex assembly(GO:1902605) |
| 2.6 |
10.4 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 2.6 |
18.0 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 2.6 |
5.1 |
GO:0021604 |
cranial nerve structural organization(GO:0021604) |
| 2.6 |
7.7 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 2.6 |
30.6 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 2.5 |
30.5 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 2.5 |
5.1 |
GO:0071336 |
regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 2.5 |
12.7 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 2.5 |
27.9 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 2.5 |
15.2 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 2.5 |
17.7 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 2.5 |
10.1 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 2.5 |
12.6 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 2.5 |
20.1 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 2.5 |
17.5 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 2.5 |
29.8 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 2.5 |
7.4 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 2.4 |
12.2 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 2.4 |
9.7 |
GO:0042518 |
negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
| 2.4 |
50.8 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 2.4 |
7.2 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 2.4 |
4.8 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 2.4 |
24.0 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 2.4 |
12.0 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 2.4 |
4.8 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 2.4 |
16.7 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 2.4 |
38.1 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 2.4 |
30.9 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 2.4 |
14.2 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 2.3 |
77.0 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 2.3 |
86.3 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 2.3 |
9.3 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 2.3 |
4.6 |
GO:0048169 |
regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 2.3 |
2.3 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 2.3 |
53.1 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 2.3 |
2.3 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 2.3 |
27.5 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 2.3 |
20.6 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 2.3 |
9.2 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 2.3 |
6.8 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 2.3 |
4.5 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 2.3 |
18.1 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 2.3 |
6.8 |
GO:1903044 |
protein transport into membrane raft(GO:0032596) protein localization to membrane raft(GO:1903044) |
| 2.2 |
4.5 |
GO:0010820 |
regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
| 2.2 |
20.2 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 2.2 |
2.2 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 2.2 |
35.5 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 2.2 |
11.1 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 2.2 |
6.6 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 2.2 |
48.7 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 2.2 |
19.9 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 2.2 |
11.0 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 2.2 |
17.6 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 2.2 |
6.6 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 2.2 |
6.6 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 2.2 |
4.4 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 2.2 |
8.7 |
GO:0051684 |
establishment of Golgi localization(GO:0051683) maintenance of Golgi location(GO:0051684) |
| 2.1 |
32.0 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 2.1 |
10.6 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 2.1 |
21.2 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 2.1 |
12.7 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 2.1 |
19.0 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 2.1 |
19.0 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 2.1 |
27.3 |
GO:0010640 |
regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
| 2.1 |
2.1 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 2.1 |
4.2 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 2.1 |
10.4 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 2.1 |
4.1 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 2.1 |
8.3 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 2.1 |
8.3 |
GO:0072578 |
neurotransmitter-gated ion channel clustering(GO:0072578) |
| 2.1 |
4.1 |
GO:1902669 |
positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
| 2.0 |
79.9 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 2.0 |
12.3 |
GO:0039535 |
regulation of RIG-I signaling pathway(GO:0039535) positive regulation of RIG-I signaling pathway(GO:1900246) |
| 2.0 |
20.4 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 2.0 |
2.0 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 2.0 |
26.5 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 2.0 |
6.1 |
GO:0051611 |
regulation of neurotransmitter uptake(GO:0051580) negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) neurotransmitter reuptake(GO:0098810) |
| 2.0 |
6.0 |
GO:1903525 |
regulation of membrane tubulation(GO:1903525) |
| 2.0 |
8.0 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 2.0 |
6.0 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 2.0 |
8.0 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 2.0 |
11.8 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 1.9 |
50.7 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 1.9 |
31.1 |
GO:0010765 |
positive regulation of sodium ion transport(GO:0010765) |
| 1.9 |
11.6 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 1.9 |
29.0 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 1.9 |
21.2 |
GO:0035418 |
protein localization to synapse(GO:0035418) |
| 1.9 |
5.8 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 1.9 |
11.5 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 1.9 |
3.8 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 1.9 |
5.7 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 1.9 |
13.2 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) |
| 1.9 |
3.8 |
GO:0061724 |
lipophagy(GO:0061724) |
| 1.9 |
5.7 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 1.9 |
11.3 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 1.9 |
13.1 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 1.9 |
1.9 |
GO:2000015 |
regulation of determination of dorsal identity(GO:2000015) |
| 1.9 |
13.1 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 1.9 |
50.4 |
GO:0045921 |
positive regulation of exocytosis(GO:0045921) |
| 1.9 |
1.9 |
GO:2000807 |
regulation of synaptic vesicle clustering(GO:2000807) |
| 1.9 |
1.9 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 1.8 |
7.4 |
GO:0097178 |
ruffle assembly(GO:0097178) |
| 1.8 |
5.5 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 1.8 |
1.8 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 1.8 |
9.1 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 1.8 |
1.8 |
GO:0090148 |
membrane fission(GO:0090148) |
| 1.8 |
1.8 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 1.8 |
21.7 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
| 1.8 |
3.6 |
GO:0043323 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 1.8 |
5.4 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 1.8 |
18.0 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 1.8 |
25.0 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 1.8 |
3.6 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 1.8 |
73.9 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 1.7 |
26.2 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 1.7 |
10.4 |
GO:0071071 |
regulation of phospholipid biosynthetic process(GO:0071071) |
| 1.7 |
1.7 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 1.7 |
6.8 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 1.7 |
15.2 |
GO:0036230 |
granulocyte activation(GO:0036230) |
| 1.7 |
6.7 |
GO:0072362 |
regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) |
| 1.7 |
6.7 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 1.7 |
10.0 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 1.7 |
1.7 |
GO:0046831 |
regulation of RNA export from nucleus(GO:0046831) |
| 1.7 |
1.7 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 1.7 |
1.7 |
GO:0034764 |
positive regulation of transmembrane transport(GO:0034764) |
| 1.7 |
3.3 |
GO:0045988 |
negative regulation of striated muscle contraction(GO:0045988) |
| 1.7 |
5.0 |
GO:2000834 |
androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 1.7 |
1.7 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 1.7 |
16.6 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 1.7 |
8.3 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 1.7 |
1.7 |
GO:0032055 |
negative regulation of translation in response to stress(GO:0032055) |
| 1.6 |
1.6 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 1.6 |
8.2 |
GO:0006678 |
glucosylceramide metabolic process(GO:0006678) |
| 1.6 |
16.4 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 1.6 |
1.6 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 1.6 |
29.3 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 1.6 |
11.4 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 1.6 |
1.6 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 1.6 |
6.5 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 1.6 |
17.7 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 1.6 |
147.7 |
GO:0071804 |
cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 1.6 |
4.8 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 1.6 |
6.4 |
GO:0061718 |
NADH regeneration(GO:0006735) regulation of anion channel activity(GO:0010359) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 1.6 |
9.5 |
GO:0051775 |
response to redox state(GO:0051775) |
| 1.6 |
6.3 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 1.6 |
12.6 |
GO:0061014 |
positive regulation of mRNA catabolic process(GO:0061014) |
| 1.6 |
10.9 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 1.6 |
7.8 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 1.6 |
3.1 |
GO:1902172 |
keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 1.5 |
4.6 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 1.5 |
9.3 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 1.5 |
10.8 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 1.5 |
1.5 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 1.5 |
3.1 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 1.5 |
39.8 |
GO:0014044 |
Schwann cell development(GO:0014044) myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 1.5 |
12.2 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 1.5 |
225.1 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 1.5 |
27.4 |
GO:0032418 |
lysosome localization(GO:0032418) |
| 1.5 |
6.1 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 1.5 |
1.5 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 1.5 |
4.5 |
GO:0030070 |
insulin processing(GO:0030070) |
| 1.5 |
1.5 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 1.5 |
7.4 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 1.5 |
4.4 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 1.5 |
1.5 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 1.5 |
14.7 |
GO:0060999 |
positive regulation of dendritic spine development(GO:0060999) |
| 1.5 |
32.0 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 1.5 |
1.5 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 1.4 |
23.2 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 1.4 |
15.9 |
GO:0038179 |
neurotrophin signaling pathway(GO:0038179) neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 1.4 |
5.8 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 1.4 |
4.3 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 1.4 |
50.8 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 1.4 |
2.8 |
GO:1902995 |
regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 1.4 |
8.4 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 1.4 |
1.4 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 1.4 |
1.4 |
GO:1903069 |
regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 1.4 |
6.9 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 1.4 |
4.1 |
GO:0045908 |
negative regulation of vasodilation(GO:0045908) |
| 1.4 |
2.7 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 1.4 |
2.7 |
GO:0010624 |
regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
| 1.4 |
19.2 |
GO:0044243 |
collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 1.4 |
2.7 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 1.4 |
2.7 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) angiotensin-activated signaling pathway involved in heart process(GO:0086098) negative regulation of membrane depolarization(GO:1904180) regulation of caveolin-mediated endocytosis(GO:2001286) |
| 1.4 |
6.8 |
GO:0006903 |
vesicle targeting(GO:0006903) |
| 1.3 |
2.7 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 1.3 |
8.1 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 1.3 |
2.7 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
| 1.3 |
6.6 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 1.3 |
7.9 |
GO:0015791 |
polyol transport(GO:0015791) |
| 1.3 |
7.9 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 1.3 |
4.0 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 1.3 |
5.3 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 1.3 |
2.6 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 1.3 |
2.6 |
GO:0090045 |
positive regulation of deacetylase activity(GO:0090045) |
| 1.3 |
3.9 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 1.3 |
5.2 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 1.3 |
2.6 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 1.3 |
10.3 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 1.3 |
10.3 |
GO:0044144 |
regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 1.3 |
5.2 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 1.3 |
6.4 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 1.3 |
16.6 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 1.3 |
26.7 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 1.3 |
5.1 |
GO:0032096 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 1.3 |
3.8 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 1.2 |
2.5 |
GO:0060065 |
uterus development(GO:0060065) |
| 1.2 |
2.5 |
GO:0033700 |
phospholipid efflux(GO:0033700) |
| 1.2 |
1.2 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 1.2 |
3.7 |
GO:1901524 |
regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
| 1.2 |
17.4 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 1.2 |
7.4 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 1.2 |
4.9 |
GO:0009597 |
detection of virus(GO:0009597) |
| 1.2 |
65.0 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 1.2 |
6.1 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 1.2 |
7.3 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 1.2 |
8.5 |
GO:0021670 |
lateral ventricle development(GO:0021670) |
| 1.2 |
6.1 |
GO:0071635 |
negative regulation of transforming growth factor beta production(GO:0071635) |
| 1.2 |
3.6 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 1.2 |
1.2 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 1.2 |
2.4 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 1.2 |
4.8 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 1.2 |
4.8 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 1.2 |
2.4 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 1.2 |
5.9 |
GO:0033599 |
regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 1.2 |
4.7 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 1.2 |
2.3 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 1.2 |
9.2 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 1.1 |
1.1 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 1.1 |
11.4 |
GO:0043330 |
response to exogenous dsRNA(GO:0043330) |
| 1.1 |
1.1 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 1.1 |
4.5 |
GO:0006983 |
ER overload response(GO:0006983) |
| 1.1 |
19.1 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 1.1 |
3.4 |
GO:0042891 |
antibiotic transport(GO:0042891) |
| 1.1 |
7.8 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 1.1 |
19.0 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 1.1 |
5.6 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 1.1 |
8.8 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 1.1 |
3.3 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 1.1 |
6.6 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 1.1 |
8.8 |
GO:0048194 |
Golgi vesicle budding(GO:0048194) |
| 1.1 |
3.3 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 1.1 |
3.3 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 1.1 |
1.1 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 1.1 |
3.2 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 1.1 |
1.1 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 1.1 |
5.4 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 1.1 |
8.6 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 1.1 |
8.6 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 1.1 |
19.3 |
GO:0048278 |
vesicle docking(GO:0048278) |
| 1.1 |
3.2 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 1.1 |
3.2 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 1.1 |
7.4 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 1.1 |
16.9 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 1.1 |
8.4 |
GO:0001845 |
phagolysosome assembly(GO:0001845) |
| 1.1 |
9.5 |
GO:0060997 |
dendritic spine morphogenesis(GO:0060997) |
| 1.0 |
3.1 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 1.0 |
4.2 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 1.0 |
10.4 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 1.0 |
3.1 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 1.0 |
1.0 |
GO:0072393 |
microtubule anchoring at microtubule organizing center(GO:0072393) |
| 1.0 |
8.3 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 1.0 |
56.8 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 1.0 |
5.1 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 1.0 |
7.2 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 1.0 |
2.1 |
GO:0010954 |
positive regulation of protein processing(GO:0010954) |
| 1.0 |
4.1 |
GO:0048012 |
hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 1.0 |
26.5 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 1.0 |
4.1 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 1.0 |
7.1 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 1.0 |
3.0 |
GO:0051036 |
multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) regulation of endosome size(GO:0051036) |
| 1.0 |
3.0 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 1.0 |
1.0 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 1.0 |
10.1 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 1.0 |
13.1 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 1.0 |
62.5 |
GO:0036503 |
ERAD pathway(GO:0036503) |
| 1.0 |
35.4 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 1.0 |
3.8 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 1.0 |
36.3 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 1.0 |
18.1 |
GO:0060749 |
mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.9 |
2.8 |
GO:0046104 |
thymidine metabolic process(GO:0046104) |
| 0.9 |
0.9 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.9 |
0.9 |
GO:0070230 |
positive regulation of lymphocyte apoptotic process(GO:0070230) |
| 0.9 |
1.8 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.9 |
0.9 |
GO:0031282 |
regulation of guanylate cyclase activity(GO:0031282) |
| 0.9 |
4.6 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.9 |
13.7 |
GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.9 |
3.6 |
GO:0046851 |
negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
| 0.9 |
10.9 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.9 |
5.4 |
GO:0045104 |
intermediate filament cytoskeleton organization(GO:0045104) |
| 0.9 |
2.7 |
GO:0046077 |
dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.9 |
1.8 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.9 |
5.2 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.9 |
3.5 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.9 |
1.7 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.9 |
6.1 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.9 |
58.6 |
GO:0000209 |
protein polyubiquitination(GO:0000209) |
| 0.9 |
18.0 |
GO:0048008 |
platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.9 |
5.1 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.9 |
8.5 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.8 |
3.4 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.8 |
4.2 |
GO:0042297 |
vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
| 0.8 |
2.5 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.8 |
6.7 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.8 |
6.7 |
GO:0032411 |
positive regulation of transporter activity(GO:0032411) |
| 0.8 |
1.7 |
GO:1900424 |
regulation of defense response to bacterium(GO:1900424) |
| 0.8 |
2.5 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.8 |
4.1 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.8 |
0.8 |
GO:1904338 |
regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.8 |
1.6 |
GO:0009838 |
abscission(GO:0009838) |
| 0.8 |
2.4 |
GO:2000314 |
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.8 |
1.6 |
GO:1901673 |
regulation of mitotic spindle assembly(GO:1901673) |
| 0.8 |
1.6 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 0.8 |
4.0 |
GO:1902993 |
positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 0.8 |
0.8 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.8 |
6.4 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.8 |
9.3 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.8 |
7.7 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.8 |
10.8 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.8 |
1.5 |
GO:0045324 |
late endosome to vacuole transport(GO:0045324) |
| 0.8 |
1.5 |
GO:0031935 |
regulation of chromatin silencing(GO:0031935) |
| 0.8 |
0.8 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
| 0.8 |
24.3 |
GO:0000045 |
autophagosome assembly(GO:0000045) |
| 0.8 |
13.5 |
GO:0051220 |
cytoplasmic sequestering of protein(GO:0051220) |
| 0.8 |
0.8 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.7 |
4.5 |
GO:0009136 |
ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.7 |
0.7 |
GO:0061050 |
regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
| 0.7 |
11.2 |
GO:0031114 |
negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
| 0.7 |
0.7 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.7 |
3.7 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.7 |
3.7 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.7 |
1.5 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.7 |
3.7 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.7 |
7.3 |
GO:0015825 |
L-serine transport(GO:0015825) |
| 0.7 |
2.2 |
GO:0015824 |
proline transport(GO:0015824) |
| 0.7 |
4.3 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.7 |
0.7 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.7 |
3.5 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.7 |
3.5 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.7 |
4.8 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.7 |
2.1 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.7 |
2.1 |
GO:0051351 |
positive regulation of ligase activity(GO:0051351) |
| 0.7 |
2.0 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.7 |
3.4 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.7 |
4.7 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
| 0.7 |
1.3 |
GO:0034143 |
regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
| 0.7 |
2.7 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.7 |
1.3 |
GO:1901679 |
nucleotide transmembrane transport(GO:1901679) |
| 0.7 |
4.6 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.7 |
1.3 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.7 |
3.3 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.7 |
0.7 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.7 |
7.8 |
GO:0001919 |
regulation of receptor recycling(GO:0001919) |
| 0.6 |
4.5 |
GO:1900006 |
positive regulation of dendrite development(GO:1900006) |
| 0.6 |
5.8 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.6 |
2.6 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.6 |
6.4 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.6 |
2.6 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.6 |
1.9 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.6 |
1.9 |
GO:0030262 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.6 |
0.6 |
GO:0071380 |
cellular response to prostaglandin stimulus(GO:0071379) cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.6 |
5.0 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.6 |
2.5 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.6 |
4.3 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.6 |
8.5 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.6 |
6.1 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.6 |
9.1 |
GO:0060079 |
excitatory postsynaptic potential(GO:0060079) |
| 0.6 |
15.5 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.6 |
2.4 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.6 |
0.6 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.6 |
2.4 |
GO:0042755 |
eating behavior(GO:0042755) |
| 0.6 |
4.7 |
GO:0001990 |
regulation of systemic arterial blood pressure by hormone(GO:0001990) |
| 0.6 |
1.8 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
| 0.6 |
9.3 |
GO:0072595 |
maintenance of protein localization in organelle(GO:0072595) |
| 0.6 |
3.5 |
GO:0015838 |
amino-acid betaine transport(GO:0015838) |
| 0.6 |
2.3 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.6 |
2.3 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.6 |
2.9 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.6 |
9.8 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.6 |
2.3 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.6 |
2.8 |
GO:1903624 |
regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.6 |
1.1 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.6 |
2.3 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.6 |
2.2 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.6 |
1.1 |
GO:0030889 |
negative regulation of B cell proliferation(GO:0030889) |
| 0.5 |
0.5 |
GO:0086009 |
membrane repolarization(GO:0086009) |
| 0.5 |
20.7 |
GO:0042073 |
intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
| 0.5 |
2.7 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.5 |
2.7 |
GO:0015692 |
vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
| 0.5 |
0.5 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.5 |
1.1 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.5 |
3.7 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.5 |
16.3 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.5 |
3.1 |
GO:0044058 |
regulation of digestive system process(GO:0044058) |
| 0.5 |
2.6 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.5 |
1.6 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.5 |
2.1 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.5 |
3.1 |
GO:0090280 |
positive regulation of calcium ion import(GO:0090280) |
| 0.5 |
4.1 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.5 |
6.1 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.5 |
5.6 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.5 |
4.6 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.5 |
1.0 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.5 |
3.5 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.5 |
1.0 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.5 |
0.5 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.5 |
3.8 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.5 |
2.8 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.5 |
7.1 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.5 |
1.4 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.5 |
3.8 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 0.5 |
3.3 |
GO:0042506 |
tyrosine phosphorylation of Stat5 protein(GO:0042506) regulation of tyrosine phosphorylation of Stat5 protein(GO:0042522) positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
| 0.5 |
1.4 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.5 |
0.5 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.5 |
0.5 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.5 |
0.5 |
GO:0071609 |
chemokine (C-C motif) ligand 5 production(GO:0071609) |
| 0.5 |
1.4 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.5 |
3.7 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.4 |
39.1 |
GO:0007018 |
microtubule-based movement(GO:0007018) |
| 0.4 |
1.3 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.4 |
1.8 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.4 |
3.1 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.4 |
1.3 |
GO:0002093 |
auditory receptor cell morphogenesis(GO:0002093) |
| 0.4 |
1.8 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.4 |
7.5 |
GO:0070098 |
chemokine-mediated signaling pathway(GO:0070098) |
| 0.4 |
2.7 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.4 |
2.7 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.4 |
4.8 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.4 |
0.4 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.4 |
0.9 |
GO:0009247 |
glycolipid biosynthetic process(GO:0009247) |
| 0.4 |
2.2 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.4 |
0.9 |
GO:0002922 |
positive regulation of humoral immune response(GO:0002922) |
| 0.4 |
0.4 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.4 |
1.3 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.4 |
1.3 |
GO:0008206 |
bile acid metabolic process(GO:0008206) |
| 0.4 |
9.0 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.4 |
1.3 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.4 |
1.3 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.4 |
1.7 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.4 |
0.8 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.4 |
2.1 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.4 |
5.5 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.4 |
2.1 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.4 |
0.4 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.4 |
2.8 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.4 |
1.6 |
GO:0045346 |
regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.4 |
2.4 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.4 |
2.0 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.4 |
0.8 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.4 |
1.6 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.4 |
2.4 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.4 |
1.5 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.4 |
1.2 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.4 |
1.1 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.4 |
1.1 |
GO:0001881 |
receptor recycling(GO:0001881) |
| 0.4 |
1.1 |
GO:0021747 |
cochlear nucleus development(GO:0021747) |
| 0.4 |
1.1 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.4 |
1.1 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.4 |
6.0 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.4 |
1.5 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.4 |
2.2 |
GO:0090043 |
tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.4 |
1.5 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.4 |
0.7 |
GO:0010520 |
regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.4 |
4.3 |
GO:0033135 |
regulation of peptidyl-serine phosphorylation(GO:0033135) |
| 0.4 |
9.9 |
GO:1901216 |
positive regulation of neuron death(GO:1901216) |
| 0.3 |
1.0 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.3 |
2.1 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.3 |
5.5 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.3 |
3.4 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.3 |
1.7 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.3 |
1.3 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.3 |
1.6 |
GO:0008655 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.3 |
3.9 |
GO:0030819 |
positive regulation of cAMP biosynthetic process(GO:0030819) |
| 0.3 |
1.3 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.3 |
2.9 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.3 |
1.9 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.3 |
1.0 |
GO:0009644 |
response to light intensity(GO:0009642) response to high light intensity(GO:0009644) |
| 0.3 |
1.9 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.3 |
0.9 |
GO:0060785 |
regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
| 0.3 |
0.6 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.3 |
14.2 |
GO:0055072 |
iron ion homeostasis(GO:0055072) |
| 0.3 |
0.9 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.3 |
5.4 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.3 |
0.3 |
GO:0072367 |
regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
| 0.3 |
4.6 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.3 |
0.6 |
GO:0060633 |
negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
| 0.3 |
4.3 |
GO:0002931 |
response to ischemia(GO:0002931) |
| 0.3 |
1.7 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.3 |
1.7 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.3 |
1.1 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.3 |
1.1 |
GO:0009227 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.3 |
7.8 |
GO:0071806 |
intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
| 0.3 |
6.5 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.3 |
1.5 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.3 |
1.0 |
GO:1902224 |
cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.2 |
1.2 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.2 |
4.3 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.2 |
19.7 |
GO:0098792 |
xenophagy(GO:0098792) |
| 0.2 |
0.5 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.2 |
0.2 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.2 |
9.9 |
GO:0006906 |
vesicle fusion(GO:0006906) |
| 0.2 |
1.4 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.2 |
4.0 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.2 |
1.1 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.2 |
2.0 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.2 |
1.3 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.2 |
0.7 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.2 |
1.3 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.2 |
2.4 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.2 |
2.6 |
GO:0030968 |
endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.2 |
1.1 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.2 |
0.6 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.2 |
0.8 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.2 |
15.0 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.2 |
0.4 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.2 |
1.0 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.2 |
0.4 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.2 |
1.1 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.2 |
2.3 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.2 |
0.7 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.2 |
1.6 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.2 |
0.4 |
GO:0045072 |
interferon-gamma biosynthetic process(GO:0042095) regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.2 |
3.4 |
GO:0006836 |
neurotransmitter transport(GO:0006836) |
| 0.2 |
0.5 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.2 |
0.9 |
GO:0060004 |
reflex(GO:0060004) |
| 0.2 |
2.0 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.2 |
0.8 |
GO:0007143 |
female meiotic division(GO:0007143) |
| 0.2 |
0.5 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.2 |
0.2 |
GO:0033206 |
meiotic cytokinesis(GO:0033206) |
| 0.1 |
1.0 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.1 |
6.7 |
GO:0006497 |
protein lipidation(GO:0006497) |
| 0.1 |
1.0 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 |
1.2 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.1 |
1.9 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.1 |
1.0 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 |
0.8 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.1 |
1.0 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.1 |
0.5 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.1 |
0.8 |
GO:0009098 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.1 |
0.7 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.1 |
1.4 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.1 |
0.1 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.1 |
0.3 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.1 |
0.8 |
GO:0031110 |
regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.1 |
0.4 |
GO:0061615 |
glycolytic process through fructose-6-phosphate(GO:0061615) |
| 0.1 |
0.4 |
GO:0002679 |
respiratory burst involved in defense response(GO:0002679) |
| 0.1 |
3.1 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.1 |
0.3 |
GO:0051792 |
medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.1 |
0.4 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.1 |
4.1 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.1 |
0.1 |
GO:0001963 |
synaptic transmission, dopaminergic(GO:0001963) |
| 0.1 |
0.5 |
GO:0006361 |
transcription initiation from RNA polymerase I promoter(GO:0006361) termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 |
20.7 |
GO:0016567 |
protein ubiquitination(GO:0016567) |
| 0.1 |
0.8 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 0.1 |
0.5 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 |
0.1 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.1 |
0.3 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.1 |
0.3 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 |
0.3 |
GO:0006547 |
histidine metabolic process(GO:0006547) imidazole-containing compound metabolic process(GO:0052803) |
| 0.1 |
2.5 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.1 |
0.4 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 |
0.2 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 |
0.8 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 |
0.4 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.1 |
0.2 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
0.2 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 |
0.2 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.1 |
GO:0033866 |
nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.0 |
0.3 |
GO:0046070 |
dGTP metabolic process(GO:0046070) |
| 0.0 |
0.3 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.0 |
0.2 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.0 |
0.2 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.0 |
0.2 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.0 |
0.0 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.0 |
0.1 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.0 |
0.1 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.0 |
0.1 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.0 |
0.4 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.0 |
0.1 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.0 |
GO:0045725 |
positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.0 |
0.0 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
